SPTX SEAPORT THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, SEAPORT THERAPEUTICS INC reported revenue of n/a, net income of −$62.6M and diluted EPS of −$1.78.
SPTX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$62.6M, EPS −$1.78
- Quarter ended Mar 31, 2026: revenue n/a, net income −$25.4M, EPS −$10.34
- Quarter ended Jun 30, 2025: revenue n/a, net income −$15.1M, EPS −$6.40
- Quarter ended Mar 31, 2025: revenue n/a, net income −$13.1M, EPS −$5.65
SPTX balance sheet
- Jun 30, 2026: cash $64.2M, total assets $442M, total liabilities $19.1M, shareholders' equity $423M
- Mar 31, 2026: cash $52.9M, total assets $228M, total liabilities $18.0M, shareholders' equity −$116M
- Dec 31, 2025: cash $46.0M, total assets $249M, total liabilities $16.2M, shareholders' equity −$92.5M